• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Aditxt Shares Dipped Over 58%; Here Are 82 Biggest Movers From Friday

    9/19/22 1:53:09 AM ET
    $AAOI
    $ACET
    $ADTX
    $AIMD
    Semiconductors
    Technology
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AAOI alert in real time by email

    Gainers

    • Panbela Therapeutics, Inc. (NASDAQ:PBLA) shares jumped 53% to close at $0.58 on Friday.
    • Applied Optoelectronics, Inc. (NASDAQ:AAOI) shares climbed 50.4% to settle at $3.76 on Friday after the company announced the sale of its Chinese manufacturing facilities to Yuhan Optoelectronic Technology for $150 million.
    • iBio, Inc. (NYSE:IBIO) gained 49.8% to close at $0.46.
    • Armata Pharmaceuticals, Inc. (NYSE:ARMP) surged 31.2% to close at $4.21. Armata Pharmaceuticals, last month, posted a Q2 loss of $0.26 per share.
    • Axcella Health Inc. (NASDAQ:AXLA) jumped 29.6% to close at $2.41. Axcella Health, last month, posted a Q2 loss of $0.40 per share.
    • Anixa Biosciences, Inc. (NASDAQ:ANIX) gained 27.5% to close at $5.71.
    • Lannett Company, Inc. (NYSE:LCI) gained 25.1% to close at $0.5756. Lannett Company, last month, reported Q4 FY22 sales of $74.2 million, down from $106 million a year ago
    • Integrated Media Technology Limited (NASDAQ:IMTE) climbed 21.5% to close at $1.75.
    • Decisionpoint Systems, Inc. (NASDAQ:DPSI) rose 20.8% to close at $5.93.
    • TMC the metals company Inc. (NASDAQ:TMC) gained 20.2% to close at $1.25.
    • Dawson Geophysical Company (NASDAQ:DWSN) surged 19.1% to close at $2.00.
    • Nano Labs Ltd (NASDAQ:NA) jumped 18.8% to close at $5.56.
    • Alaunos Therapeutics, Inc. (NASDAQ:TCRT) climbed 18.5% to close at $2.50 after dropping 38% on Thursday.
    • Palatin Technologies, Inc. (NYSE:PTN) rose 18.3% to close at $7.96.
    • Palatin Technologies recently announced the initiation of patient recruitment for its Phase 2 study evaluating oral PL8177 in ulcerative colitis.
    • Enzo Biochem, Inc. (NYSE:ENZ) gained 18.1% to settle at $2.67.
    • BayFirst Financial Corp. (NASDAQ:BAFN) surged 18% to close at $21.65.
    • Bright Minds Biosciences Inc. (NASDAQ:DRUG) gained 17.2% to close at $1.50.
    • Studio City International Holdings Limited (NYSE:MSC) rose 16.9% to close at $1.80.
    • Forian Inc. (NASDAQ:FORA) gained 16.5% to close at $4.10.
    • Digital Ally, Inc. (NASDAQ:DGLY) jumped 15.5% to settle at $0.62.
    • SoundHound AI, Inc. (NASDAQ:SOUN) rose 15.1% to close at $3.74.
    • Intrusion Inc. (NASDAQ:INTZ) gained 14.4% to close at $5.01.
    • Emclaire Financial Corp (NASDAQ:EMCF) rose 13.6% to close at $36.50.
    • Velocity Financial, Inc. (NYSE:VEL) gained 10.7% to close at $13.00.
    • Azure Power Global Limited (NYSE:AZRE) rose 10.2% to settle at $5.97.
    • Alpha Tau Medical Ltd. (NASDAQ:DRTS) jumped 9.1% to close at $6.09.
    • Gogo Inc. (NASDAQ:GOGO) jumped 8.9% to close at $13.32.
    • Harmonic Inc. (NASDAQ:HLIT) gained 6.1% to close at $11.88. Needham maintained Harmonic with a Buy and raised the price target from $15 to $17.
    • JanOne Inc. (NASDAQ:JAN) shares gained 4.6% to close at $2.49. The company executed a term sheet to acquire Soin Therapeutics LLC and its product, a patent-pending, novel formulation of low dose naltrexone.


    Losers

    • Aditxt, Inc. (NASDAQ:ADTX) shares dipped 58.5% to close at $4.31 on Friday after the company announced pricing of $20 million public offering of $6 per share. Dawson James downgraded Aditxt from Buy to Neutral.
    • FOXO Technologies Inc. (NYSE:FOXO) shares fell 52.1% to close at $4.02.
    • Esports Entertainment Group, Inc. (NASDAQ:GMBL) declined 46.2% to close at $0.1750 after the company reported pricing of $7.5 million public offering of common stock and warrants.
    • Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) fell 45.9% to close at $8.99.
    • Nabriva Therapeutics plc (NASDAQ:NBRV) declined 43.4% to settle at $3.82 following effect of 1:25 reverse stock split.
    • Scienjoy Holding Corporation (NASDAQ:SJ) declined 38.6% to close at $3.07. Scienjoy Holding recently posted Q2 sales of $75.60 million.
    • Getty Images Holdings, Inc. (NYSE:GETY) dropped 36.4% to close at $8.49.
    • Comera Life Sciences Holdings, Inc. (NASDAQ:CMRA) fell 30.5% to close at $2.48 after jumping over 25% on Thursday.
    • Senti Biosciences, Inc. (NASDAQ:SNTI) declined 28.9% to close at $1.60. Senti Biosciences, last month, posted a Q2 loss of $0.86 per share.
    • Pagaya Technologies Ltd. (NASDAQ:PGY) fell 28.7% to close at $7.87.
    • NeuroBo Pharmaceuticals, Inc. (NASDAQ:NRBO) declined 27.8% to close at $17.92. NeuroBo Pharmaceuticals recently announced Dong-A has licensed its global exclusive development rights of DA-1241 for type 2 diabetes and non-alcoholic fatty hepatitis and DA-1726 for obesity and non-alcoholic fatty hepatitis to NeuroBo.
    • Netcapital Inc. (NASDAQ:NCPL) fell 26.3% to close at $2.05. Netcapital recently announced revenue growth of 114% for first quarter.
    • Ventoux CCM Acquisition Corp. (NASDAQ:VTAQ) fell 22.7% to close at $4.56.
    • FedEx Corporation (NYSE:FDX) fell 21.4% to close at $161.02 after the company issued preliminary Q1 earnings results. Keybanc and JP Morgan also downgraded the stock.
    • NCR Corporation (NYSE:NCR) shares declined 20.3% to close at $23.20 after the company announced it will separate into two independent, publicly traded companies – one focused on digital commerce, the other on ATMs.
    • D-Wave Quantum Inc. (NYSE:QBTS) fell 20.2% to settle at $6.64.
    • Midatech Pharma plc (NASDAQ:MTP) fell 20% to close at $0.5330.
    • Caladrius Biosciences, Inc. (NASDAQ:LSTA) dipped 20% to close at $5.00.
    • AMTD Digital Inc. (NYSE:HKD) fell 19.8% to close at $108.00 after tumbling around 29% on Thursday.
    • Alignment Healthcare, Inc. (NASDAQ:ALHC) dropped 19.5% to settle at $12.88 after the company announced a secondary offering.
    • Apexigen, Inc. (NASDAQ:APGN) declined 19.1% to close at $5.76. Apexigen recently announced the presentation of new data from a Phase 2 trial evaluating sotigalimab in combination with neoadjuvant chemoradiation for resectable esophageal and gastroesophageal junction cancers.
    • Ra Medical Systems, Inc. (NYSE:RMED) dipped 19.1% to settle at $0.1365.
    • PepGen Inc. (NASDAQ:PEPG) fell 18.9% to settle at $5.63.
    • PaxMedica, Inc. (NASDAQ:PXMD) fell 18.6% to settle at $3.16.
    • HeartBeam, Inc. (NASDAQ:BEAT) shares fell 17.7% to close at $1.91. Heartbeam shares jumped over 85% on Thursday after the company announced its patent for a 12-lead electrocardiogram patch monitor intended for detection of acute coronary syndrome and cardiac arrhythmia was issued by the USPTO.
    • Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) fell 17.6% to close at $10.80. Keybanc initiated coverage on Recursion Pharmaceuticals with an Overweight rating and announced a price target of $20.
    • Rubius Therapeutics, Inc. (NASDAQ:RUBY) fell 17.5% to close at $0.5702.
    • 1847 Holdings LLC (NYSE:EFSH) dropped 17.5% to close at $2.0390.
    • Addentax Group Corp. (NASDAQ:ATXG) fell 17.2% to settle at $4.47.
    • Kensington Capital Acquisition Corp. IV (NYSE:AMPX) fell 17% to close at $8.30 on Friday after gaining 11% on Thursday.
    • Avadel Pharmaceuticals plc (NASDAQ:AVDL) dipped 14.9% to close at $5.08.
    • Atara Biotherapeutics, Inc. (NASDAQ:ATRA) declined 14% to close at $4.04.
    • C4 Therapeutics, Inc. (NASDAQ:CCCC) dipped 13.6% to close at $9.82.
    • Ainos, Inc. (NASDAQ:AIMD) fell 13.4% to close at $1.61.
    • Foghorn Therapeutics Inc. (NASDAQ:FHTX) dropped 13.4% to settle at $8.60.
    • Onion Global Limited (NYSE:OG) declined 13.1% to close at $0.4390.
    • Borqs Technologies, Inc. (NASDAQ:BRQS) fell 12.4% to close at $0.9018.
    • Verve Therapeutics, Inc. (NASDAQ:VERV) dropped 11.9% to close at $36.55.
    • WestRock Company (NYSE:WRK) declined 11.5% to close at $34.15. Jefferies maintained WestRock with a Hold and lowered the price target from $45 to $42.
    • Athersys, Inc. (NASDAQ:ATHX) fell 11.4% to close at $1.95.
    • International Paper Company (NYSE:IP) dropped 11.2% to close at $35.23 after Jefferies downgraded the stock from Hold to Underperform and lowered its price target from $40 to $31.
    • Caribou Biosciences, Inc. (NASDAQ:CRBU) dropped 11.1% to close at $11.37.
    • Carvana Co. (NYSE:CVNA) declined 11.1% to settle at $32.92 amid negative economic sentiment. A slowdown in the economy could cause consumers to cut back on spending, which would negatively impact the auto market.
    • Packaging Corporation of America (NYSE:PKG) declined 11% to close at $118.07.
    • Vipshop Holdings Limited (NYSE:VIPS) dropped 10.9% to close at $9.41.
    • Natura &Co Holding S.A. (NYSE:NTCO) fell 10.3% to close at $5.68.
    • Roblox Corporation (NYSE:RBLX) dropped 9.2% to close at $39.50 on continued downward momentum following the company's Investor Day event. Also, LightShed partner Brandon Ross tweeted the company's booking growth in August decelerated month over month. Needham maintained Roblox with a Buy and lowered the price target from $55 to $53.
    • Avis Budget Group, Inc. (NASDAQ:CAR) dipped 8.9% to close at $147.30.
    • Robinhood Markets, Inc. (NASDAQ:HOOD) fell 8.9% to settle at $10.25.
    • Adicet Bio, Inc. (NASDAQ:ACET) fell 8% to close at $15.76. Adicet Bio, last month, posted a Q2 loss of $0.56 per share.
    • UroGen Pharma Ltd. (NASDAQ:URGN) dipped 7.3% to close at $8.72. UroGen Pharma, last month, posted a Q2 loss of $1.18 per share.
    • United Parcel Service, Inc. (NYSE:UPS) shares fell 4.5% to close at $176.71 after FedEx said its fiscal first-quarter results were adversely impacted by global volume softness that accelerated in the final weeks of the quarter.
    • Amazon.com, Inc. (NASDAQ:AMZN) fell 2.2% to close at $123.53 amid overall market weakness following bearish economic comments from FedEx.
    Get the next $AAOI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AAOI
    $ACET
    $ADTX
    $AIMD

    CompanyDatePrice TargetRatingAnalyst
    D-Wave Quantum Inc.
    $QBTS
    2/12/2026Buy
    TD Cowen
    Robinhood Markets Inc.
    $HOOD
    2/11/2026$135.00 → $100.00Buy
    Needham
    Roblox Corporation
    $RBLX
    2/9/2026$84.00Neutral → Buy
    Roth Capital
    Robinhood Markets Inc.
    $HOOD
    2/9/2026$125.00Peer Perform → Outperform
    Wolfe Research
    Roblox Corporation
    $RBLX
    2/6/2026$159.00 → $105.00Buy
    Needham
    Amazon.com Inc.
    $AMZN
    2/6/2026$300.00 → $280.00Buy
    Monness Crespi & Hardt
    Amazon.com Inc.
    $AMZN
    2/6/2026$175.00Buy → Neutral
    DA Davidson
    FedEx Corporation
    $FDX
    2/3/2026$380.00Equal Weight → Overweight
    Wells Fargo
    More analyst ratings

    $AAOI
    $ACET
    $ADTX
    $AIMD
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Connor Christopher M bought $1,009,250 worth of shares (25,000 units at $40.37) (SEC Form 4)

    4 - INTERNATIONAL PAPER CO /NEW/ (0000051434) (Issuer)

    2/2/26 5:30:10 PM ET
    $IP
    Paper
    Basic Materials

    Chief Executive Officer Silvernail Andrew K bought $1,998,965 worth of shares (50,000 units at $39.98) (SEC Form 4)

    4 - INTERNATIONAL PAPER CO /NEW/ (0000051434) (Issuer)

    1/30/26 4:47:45 PM ET
    $IP
    Paper
    Basic Materials

    Director Baskies Arnold M bought $30,400 worth of shares (10,000 units at $3.04), increasing direct ownership by 8% to 135,000 units (SEC Form 4)

    4 - Anixa Biosciences Inc (0000715446) (Issuer)

    1/29/26 8:58:38 AM ET
    $ANIX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAOI
    $ACET
    $ADTX
    $AIMD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    TD Cowen initiated coverage on D-Wave Quantum

    TD Cowen initiated coverage of D-Wave Quantum with a rating of Buy

    2/12/26 7:24:12 AM ET
    $QBTS
    EDP Services
    Technology

    Needham reiterated coverage on Robinhood Markets with a new price target

    Needham reiterated coverage of Robinhood Markets with a rating of Buy and set a new price target of $100.00 from $135.00 previously

    2/11/26 7:05:02 AM ET
    $HOOD
    Investment Bankers/Brokers/Service
    Finance

    Roblox upgraded by Roth Capital with a new price target

    Roth Capital upgraded Roblox from Neutral to Buy and set a new price target of $84.00

    2/9/26 6:58:32 AM ET
    $RBLX
    Computer Software: Prepackaged Software
    Technology

    $AAOI
    $ACET
    $ADTX
    $AIMD
    SEC Filings

    View All

    SEC Form 25-NSE filed by Avadel Pharmaceuticals plc

    25-NSE - AVADEL PHARMACEUTICALS PLC (0001012477) (Subject)

    2/12/26 9:53:02 AM ET
    $AVDL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Avadel Pharmaceuticals plc filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Regulation FD Disclosure

    8-K - AVADEL PHARMACEUTICALS PLC (0001012477) (Filer)

    2/12/26 7:40:14 AM ET
    $AVDL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 144 filed by Applied Optoelectronics Inc.

    144 - APPLIED OPTOELECTRONICS, INC. (0001158114) (Subject)

    2/11/26 5:14:22 PM ET
    $AAOI
    Semiconductors
    Technology

    $AAOI
    $ACET
    $ADTX
    $AIMD
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    March 11, 2025 - FDA Roundup: March 11, 2025

    For Immediate Release: March 11, 2025 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:Today, the FDA published a General Correspondence Letter issued to Mid-Link Technology Testing Co., Ltd. The FDA is vigilant in ensuring data submitted to the FDA can be relied upon to assess the effectiveness, safety, or risk of a device. The FDA has noted an incr

    3/13/25 3:14:00 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    FDA Approval for LEVOFLOXACIN issued to LANNETT CO INC

    Submission status for LANNETT CO INC's drug LEVOFLOXACIN (SUPPL-11) with active ingredient LEVOFLOXACIN has changed to 'Approval' on 09/20/2024. Application Category: ANDA, Application Number: 205222, Application Classification: Labeling

    9/24/24 4:39:48 AM ET
    $LCI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for MYCOPHENOLATE MOFETIL issued to LANNETT CO INC

    Submission status for LANNETT CO INC's drug MYCOPHENOLATE MOFETIL (SUPPL-7) with active ingredient MYCOPHENOLATE MOFETIL has changed to 'Approval' on 08/13/2024. Application Category: ANDA, Application Number: 214525, Application Classification: REMS

    8/15/24 4:43:42 AM ET
    $LCI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAOI
    $ACET
    $ADTX
    $AIMD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    FedEx Corporation Hosts 2026 Investor Day

    Introduces Key Strategic Initiatives Supporting the Company's Vision of Making Supply Chains Smarter for Everyone Targets Strong Earnings Growth, Margin Expansion, and Adjusted Free Cash Flow Through 2029 Provides Third Fiscal Quarter Update FedEx Corp. (NYSE:FDX) today announced at its 2026 Investor Day the company's strategy to strengthen its position as the leading industrial network that powers the global economy. Looking ahead, FedEx is prioritizing premium growth in high-margin verticals, scaling its digital and AI capabilities, and further transforming its network to drive significant profit improvement and stockholder value creation. "For over five decades, FedEx has built o

    2/12/26 8:16:00 AM ET
    $FDX
    Air Freight/Delivery Services
    Consumer Discretionary

    Getty Images and NASCAR Renew Multi-Year Agreement

    A Media Snippet accompanying this announcement is available by clicking on this link. NEW YORK, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Getty Images (NYSE:GETY), a preeminent global visual content creator and marketplace, today announced the renewal of its long-standing partnership with NASCAR, extending its role as NASCAR's Official Photography Partner, a designation it has held since 2006. The agreement sees Getty Images' team of specialized motorsport photographers deliver high-quality imagery from all races and events in the NASCAR series, including NASCAR Cup Series™, NASCAR O'Reilly Auto Parts Series™, and NASCAR CRAFTSMAN Truck Series™. With exclusive, behind-the-scenes access, Getty

    2/12/26 8:00:00 AM ET
    $GETY
    Real Estate

    Recursion Reports Grant of Inducement Awards as Permitted by the Nasdaq Listing Rules

    Salt Lake City, Utah, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Recursion (NASDAQ:RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced that on February 6, 2026, the Compensation Committee of Recursion's Board of Directors approved the grant of inducement restricted stock unit (RSU) awards covering 820,431 shares of its class A common stock in the aggregate to 17 new employees under Recursion's 2024 Inducement Equity Incentive Plan (the "2024 Plan"). Each award was granted as an inducement material to the employee's commencement of employment with Recursion, or a subsidiary of Recursion, pursuant to Nasdaq Listing Rule 5635(c)(4). Each inducement

    2/12/26 7:59:00 AM ET
    $RXRX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AAOI
    $ACET
    $ADTX
    $AIMD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Legal Off. & Corp. Sec. Reinstra Mark converted options into 118,110 shares and sold $2,493,475 worth of shares (34,320 units at $72.65), increasing direct ownership by 23% to 454,322 units (SEC Form 4)

    4 - Roblox Corp (0001315098) (Issuer)

    2/11/26 6:57:26 PM ET
    $RBLX
    Computer Software: Prepackaged Software
    Technology

    Chief People & Systems Officer Chakravarthy Arvind converted options into 114,776 units of Class A Common Stock and sold $6,639,886 worth of Class A Common Stock (95,895 units at $69.24), increasing direct ownership by 33% to 240,570 units (SEC Form 4)

    4 - Roblox Corp (0001315098) (Issuer)

    2/11/26 6:56:36 PM ET
    $RBLX
    Computer Software: Prepackaged Software
    Technology

    President & CEO Baszucki David converted options into 893,068 shares and sold $19,782,756 worth of shares (272,269 units at $72.66), increasing direct ownership by 326% to 811,373 units (SEC Form 4)

    4 - Roblox Corp (0001315098) (Issuer)

    2/11/26 6:55:53 PM ET
    $RBLX
    Computer Software: Prepackaged Software
    Technology

    $AAOI
    $ACET
    $ADTX
    $AIMD
    Financials

    Live finance-specific insights

    View All

    Sylvamo Releases Fourth Quarter, Full Year Earnings

    Sylvamo (NYSE:SLVM), the world's paper company, is releasing fourth quarter and full year 2025 earnings. The company will host an audio webcast at 10 a.m. EST at investors.sylvamo.com. Management Summary from Chief Executive Officer John Sims As Sylvamo's CEO, my vision is that Sylvamo will be legendary for the way we relentlessly pursue and achieve world-class excellence in all that we do. This will create substantial and lasting value for our employees, customers and shareowners and will enable us to be the employer, supplier and investment of choice. I am committed to allocating capital wisely to create long-term value, communicating transparently, upholding our values and driving

    2/12/26 7:00:00 AM ET
    $IP
    $SLVM
    Paper
    Basic Materials

    D-Wave Quantum to Report Fourth Quarter and Year-End Fiscal Year 2025 Financial Results on February 26, 2026

    D-Wave Quantum Inc. (NYSE:QBTS) ("D-Wave"), the only dual-platform quantum computing company, providing both annealing and gate-model systems, software, and services, today announced it will release its financial results for the fourth quarter and fiscal year 2025 ended December 31, 2025 on Thursday, February 26, 2026 before market open. The press release will be available on the D-Wave Investor Relations website: https://ir.dwavesys.com/. In conjunction with this announcement, D-Wave will host a conference call on Thursday, February 26, 2026, at 8:00 a.m. (Eastern Time), to discuss the Company's financial results and business outlook. The live dial-in number is 1-844-826-3035 (domestic)

    2/12/26 7:00:00 AM ET
    $QBTS
    EDP Services
    Technology

    Senti Biosciences Completes Enrollment in Phase 1 Clinical Trial of SENTI-202 for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia (R/R AML)

    Robust SENTI-202 clinical data presented at ASH 2025 demonstrated deep, MRD-negative, durable complete remissions and a favorable safety profile Company planning for rapid advancement of SENTI-202 into R/R AML pivotal study and evaluating indication expansion to include newly diagnosed AML and pediatric AML; Preparing for FDA discussions in the first half of 2026 SENTI-202 has received Regenerative Medicine Advanced Therapy (RMAT) designation, which may enable an expedited development and review process SOUTH SAN FRANCISCO, Calif., Feb. 11, 2026 (GLOBE NEWSWIRE) --  Senti Biosciences, Inc. (NASDAQ:SNTI) ("Senti Bio"), a clinical-stage biotechnology company developing next-generatio

    2/11/26 8:35:00 AM ET
    $SNTI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AAOI
    $ACET
    $ADTX
    $AIMD
    Leadership Updates

    Live Leadership Updates

    View All

    Circana Appoints Highly Regarded Business Leaders to Board of Directors

    Chicago, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Circana LLC, a leading global provider of data, insights, and advisory services, today announced the appointment of three new members to its Board of Directors: Brian Cornell, Executive Chair of Target Corp.; Lauren Cooks Levitan, Co-Founder and Co-CEO of ROOT and Lead Independent Director at e.l.f. Beauty, Inc.; and Rohit Prasad, former Senior Vice President and Head Scientist of Artificial General Intelligence at Amazon.com, Inc. "These appointments strengthen the Board's ability to guide Circana's strategy and accelerate the value we deliver to our global clients," said Stuart Aitken, President and CEO of Circana. "We are focused on advancing

    2/11/26 8:00:00 AM ET
    $AMZN
    $TGT
    Catalog/Specialty Distribution
    Consumer Discretionary
    Department/Specialty Retail Stores

    FedEx Appoints Scott Ray as Chief Operating Officer for U.S. and Canada Surface Operations

    FedEx Corp. (NYSE:FDX) today announced the appointment of Scott Ray as chief operating officer for U.S. and Canada Surface Operations, effective June 1. He will begin transitioning into the role as COO-elect on Feb. 1. Reporting to FedEx President and CEO Raj Subramaniam, Ray will be the newest member of the FedEx Executive Committee, succeeding John Smith, who will transition to CEO of FedEx Freight as of June 1. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260126094399/en/FedEx appoints Scott Ray as chief operating officer of Surface Operations in U.S. and Canada Ray will be responsible for leading all aspects of Surface Ope

    1/27/26 8:31:00 AM ET
    $FDX
    Air Freight/Delivery Services
    Consumer Discretionary

    HeartBeam Appoints Bryan Humbarger as Chief Commercial Officer

    Brings more than 25 years of experience in building and scaling groundbreaking cardiovascular technologies Will initially focus on launching the Company's FDA-cleared 12-lead ECG system for arrhythmia assessment Will lead the Company's broader commercialization strategy across key growth initiatives, including heart attack detection and the 12-lead ECG extended-wear patch HeartBeam, Inc. (NASDAQ:BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, today announced the appointment of Bryan Humbarger as Chief Commercial Officer, effective January 22, 2026. In this newly created role, Mr. Humbarger will lead commercial strate

    1/22/26 7:00:00 AM ET
    $BEAT
    Medical/Dental Instruments
    Health Care

    $AAOI
    $ACET
    $ADTX
    $AIMD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Carvana Co.

    SC 13D/A - CARVANA CO. (0001690820) (Subject)

    12/16/24 6:13:26 PM ET
    $CVNA
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by Caribou Biosciences Inc.

    SC 13D/A - Caribou Biosciences, Inc. (0001619856) (Subject)

    12/6/24 4:06:56 PM ET
    $CRBU
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13D/A filed by Senti Biosciences Inc.

    SC 13D/A - Senti Biosciences, Inc. (0001854270) (Subject)

    12/4/24 7:08:03 PM ET
    $SNTI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care